Owens & Minor is focused on paying down debt and rethinking how it builds momentum in its “pure-play” Patient Direct business ...

Coliseum Capital, a ten-percent owner of Owens & Minor INC/VA/ (NYSE:OMI), has recently purchased shares of the company worth approximately $8.1 million. These purchases, executed between August 12 ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

NYSE:OMI 1 Year Share Price vs Fair Value Explore Owens & Minor's Fair Values from the Community and select yours ...

Owens & Minor's canceled Rotech deal eases financial risks. Click to read a full investment analysis of OMI stock and why its ...

Owens & Minor Inc (OMI) reports a 3.3% revenue increase while focusing on strategic divestitures and overcoming supply chain ...

Owens & Minor, Inc. faces financial distress with a 70% stock drop, weak margins, and strategic missteps. Click here to find out why OMI stock is a Hold.

Citigroup analyst Daniel Grosslight maintained Owens & Minor with a Buy and lowered the price target from $11 to $7. Baird ...

Owens & Minor’s Lackluster Fundamentals Owens & Minor’s Revenues declined from $9.8 billion in 2015 to $9.2 billion in 2019, owing to customer non-renewals after issues with servicing back in ...

OMI -1.00% Introduction & Market Context Owens & Minor Inc (NYSE: OMI) presented its first quarter 2025 earnings on May 8, 2025, maintaining its full-year outlook amid continued operational momentum.

Owens & Minor Inc. <OMI.N>, a distributor of medical and surgical supplies, reported on Wednesday that its first-quarter earnings fell, marking the fourth successive quarter of declining profits.